Brandtree

Who owns Arimidex?

Arimidex is made and sold by ANI Pharmaceuticals (the United States, NASDAQ: ANIP) under licence; ANI Pharmaceuticals does not own the name.[1] The Arimidex name is owned by AstraZeneca UK Limited.

Evidence: ANI Pharmaceuticals, Inc. Annual Report on Form 10-K filed 2026-02-27, SEC EDGAR, 27 February 2026. Verified from filings; last checked .

Key facts

Licensed to
ANI Pharmaceuticals, Inc. verified
Headquarters
🇺🇸 United States, Baudette
Origin
🇬🇧 United Kingdom
Category
Healthcare & pharma › Drug makers › Pharmaceuticals
Parent ticker
NASDAQ: ANIP
Last verified
· 1 sources

About Arimidex

Arimidex is a medicine whose trademark belongs to AstraZeneca UK Limited. ANI Pharmaceuticals has acquired the US marketing rights and NDA for it and sells it in the United States, but its 10-K states that the Arimidex name is licensed to ANI for US sales and is not ANI's own trademark. ANI lists it among the branded products in its Rare Disease and Brands segment.

Ownership timeline of Arimidex

Where Arimidex sits in ANI Pharmaceuticals

Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.

Where Arimidex sits in ANI Pharmaceuticals Tree of 4 brands under ANI Pharmaceuticals. ANI Pharmaceuticals ILUVIEN Inderal LA Purified Cortrophin Gel YUTIQ

Open the full ANI Pharmaceuticals ownership tree →

See the full ANI Pharmaceuticals brand portfolio (4) →

Other brands owned by ANI Pharmaceuticals

ANI Pharmaceuticals controls 5 brands on Brandtree, 5 of them in healthcare & pharma.

Also in healthcare & pharma

All ANI Pharmaceuticals brands →

Other brands in pharmaceuticals, and who owns them

The 27 brands in pharmaceuticals on Brandtree belong to 10 owners. The largest is Teva, with 4; ANI Pharmaceuticals has 4.

BrandOwnerOwner based in
Amphadase Amphastar 🇺🇸 United States
Momate Glenmark 🇮🇳 India
Ajovy Teva 🇮🇱 Israel
Celebrex Viatris 🇺🇸 United States
Brekiya Amneal 🇺🇸 United States
Evra Richter 🇭🇺 Hungary
Foracort Cipla 🇮🇳 India
Habitrol Dr. Reddy's 🇮🇳 India

Every brand in pharmaceuticals and its owner →

About the owner: ANI Pharmaceuticals

ANI Pharmaceuticals is a publicly listed company headquartered in Baudette, United States.

ANI Pharmaceuticals, Inc. is a Delaware corporation with its principal executive offices in Baudette, Minnesota. Its 10-K for 2025 calls it a diversified bio-pharmaceutical company that develops, manufactures and sells medicines through Rare Disease, Generics and Brands businesses, with a generics portfolio of more than 120 products and three owned manufacturing sites in Minnesota and New Jersey.

ANI Pharmaceuticals: full profile, brands and acquisition history →

🇬🇧 Arimidex and other British brands

Brandtree records a controlling owner for 552 brands that began in the United Kingdom. 291 of them (53%) are now controlled by a company headquartered in another country, Arimidex among them.

All British brands and who owns them →

Frequently asked questions

Who makes Arimidex?

ANI Pharmaceuticals makes and sells Arimidex under a licensing agreement.

Does ANI Pharmaceuticals own Arimidex?

No. ANI Pharmaceuticals holds a licence to make and sell Arimidex, which is not the same as owning it.

Where did Arimidex come from?

Arimidex originated in the United Kingdom.

Sources (1) & corrections

Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.

  1. [1] ANI Pharmaceuticals, Inc. Annual Report on Form 10-K filed 2026-02-27 — SEC EDGAR, SEC Form 10-K, published 27 February 2026; retrieved 18 October 2026.

Report a correction Opens a pre-filled GitHub issue. See our corrections policy.